Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction [NA]

View source ↗

Summary

A clinical trial is planned to evaluate endovascular ablation of the right greater splanchnic nerve in patients with heart failure with reduced ejection fractio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Axon Therapies, Inc. | Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF) | NA | Status: NOT_YET_RECRUITING